Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Winter;24(1):61-9.
Epub 2015 Mar 4.

A Qualitative Study of Antipsychotic Medication Experiences of Youth

Affiliations

A Qualitative Study of Antipsychotic Medication Experiences of Youth

Andrea L Murphy et al. J Can Acad Child Adolesc Psychiatry. 2015 Winter.

Abstract

Objective: To explore the lived experience of youth who are prescribed antipsychotics.

Methods: We conducted an interpretive phenomenology study of young people with recent experience of taking antipsychotics. Youth were interviewed and a staged approach was used for data analysis of transcriptions. We collected approximately 13 hours of audio from 18 youth aged 13 to 26 years between January and August of 2010.

Results: Ambivalence was significant and antipsychotic adverse effects frequently tempered benefits. Both illness and antipsychotics had significant impacts on physical and mental wellbeing with adverse effects on relationships and functioning in various contexts (e.g., school). Stigma related to both antipsychotics and illness was also prominent. Participants' limited knowledge about their antipsychotics and pressure to conform within their youth culture and context affected decisions on starting, adhering to, and persisting with treatment.

Conclusions: The lived experience of youth taking antipsychotics is complex and the benefits (e.g., symptom improvement) and consequences (e.g., adverse effects) associated with antipsychotics affect all facets of life. More research is needed to better understand youth priorities in treatment decisions and whether youth who demonstrate substantive gaps in their knowledge about antipsychotics are truly given the opportunity to be informed and engage in management decisions including whether to initiate, persist with, and discontinue treatments.

Objectif: Explorer l’expérience vécue d’adolescents à qui on a prescrit des antipsychotiques.

Méthodes: Nous avons mené une étude interprétative phénoménologique auprès de jeunes gens qui ont récemment fait l’expérience de prendre des antipsychotiques. Les jeunes ont été interviewés et une approche graduelle a servi à l’analyse des données des transcriptions. Nous avons recueilli environ 13 heures d’enregistrement audio auprès de 18 jeunes de 13 à 26 ans, entre janvier et août 2010.

Résultats: L’ambivalence était significative et les effets indésirables des antipsychotiques en ont souvent modéré les avantages. Tant la maladie que les antipsychotiques avaient des effets significatifs sur le bien-être physique et mental, et des effets indésirables sur les relations et le fonctionnement dans divers contextes (p. ex., l’école). Les stigmates liés à la maladie et aux antipsychotiques étaient également proéminents. Les connaissances limitées des participants de leurs antipsychotiques et la pression de se conformer à la culture et au contexte des jeunes influaient sur leur décision de commencer le traitement, de l’observer et d’y persister.

Conclusions: L’expérience vécue de jeunes qui prennent des antipsychotiques est complexe et les avantages (p. ex., l’amélioration des symptômes) et conséquences (p. ex., les effets indésirables) associés aux antipsychotiques affectent toutes les facettes de la vie. Il faut plus de recherche pour mieux comprendre les priorités des jeunes dans les décisions liées au traitement, et pour déterminer si l’on donne réellement aux jeunes qui démontrent des lacunes substantielles dans leurs connaissances des antipsychotiques l’occasion d’être informés et de prendre des décisions quant à la prise en charge, notamment commencer le traitement, persister et abandonner.

Keywords: antipsychotic agents; decision-making; pediatrics; physician-patient relations; qualitative research; young adults.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Youth antipsychotic experience as a double-edged saw Youth participants’ experiences with antipsychotics, reflecting the ambivalence, tension and vacillating nature of the relationship between youth and their medicine. Youth ambivalence and conflict with treatment co-existed with a desire for alternative therapies represented by the saw teeth and the physical use of the saw (i.e., push and pull). There were significant gaps in knowledge, access to adequate information, and personal and health care service supports experienced by youth in our study and are represented by the saw teeth. These gaps were often acknowledged and seen as significant for youth but they had limited ability and understanding about how to bridge the gaps. Ultimately, this led to placement of the prescriber and youth treatment decisions on opposing sides with a disconnect between the groups. The metaphor serves to depict the language used by youth in the journey of starting and persisting with treatments in a passive manner with changes being done to them as opposed to an active participant in decision-making. They discussed being “upped”, “discontinued”, “tapered off”, as instructed by clinicians and also their own process of tapering or stopping medications in an undulating pattern.

References

    1. Alessi-Severini S, Biscontri RG, Collins DM, Sareen J, Enns MW. Ten years of antipsychotic prescribing to children: A Canadian population-based study. Canadian Journal of Psychiatry. 2012;57(1):52–58. - PubMed
    1. Benner P. Quality of life: A phenomenological perspective on explanation, prediction, and understanding in nursing science. Advances in Nursing Science. 1985;8(1):1–14. - PubMed
    1. Canadian Adverse Reaction Newsletter Second-generation antipsychotics and cardiometabolic adverse reactions. 2012. (No. 22) Retrieved from: http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v22n1-eng.php.
    1. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Social Science & Medicine. 1999;49(5):651–661. - PubMed
    1. Chow S, Basky G, Teare GF, Health Quality Council . Shared decision making. Saskatoon, Sask.: Health Quality Council; 2009. Retrieved from http://hqc.sk.ca/Portals/0/documents/Shared_Decision_Making_Report_April....

LinkOut - more resources